Home > Healthcare > Medical Devices > Medical Supplies > Urometer Market

Urometer Market Size

  • Report ID: GMI11766
  • Published Date: Oct 2024
  • Report Format: PDF

Urometer Market Size

The global urometer market was valued at USD 512.4 million in 2023 and is expected to exhibit growth at a CAGR of 7.2% from 2024 to 2032. High market growth can be attributed to the ongoing advancements in urometers, increasing incidence of kidney disorders and urinary diseases, growing geriatric population, and rising number of surgeries and ICU admissions, among other contributing factors.

 

Moreover, the global aging population is more prone to urinary complications, incontinence, and chronic conditions such as kidney disease. For instance, according to a recent United Nations (UN) research report, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population. As the elderly population grows, the need for urometers in hospitals and healthcare settings increases, as older adults often require urinary monitoring, particularly in critical care and post-operative recovery.
 

Furthermore, continuous improvements in urometer technology, such as disposable and digital urometers, have made these devices more user-friendly, accurate, and hygienic. These innovations have led to increased adoption in hospitals and healthcare facilities as they improve patient safety and reduce the risk of infections.
 

Urometer is a medical device used for precise measurement of urine output, typically in critical care or post-operative settings. It is often integrated with a urinary drainage system to monitor fluid balance in patients, aiding in the diagnosis and management of kidney and urinary conditions.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The industry was valued at USD 512.4 million in 2023 and is expected to grow at a CAGR of 7.2% from 2024 to 2032. This growth is driven by advancements in technology, increasing kidney and urinary disorders, an aging population, and more surgeries and ICU admissions.

The disposable segment dominated the market in 2023 with an 82.3% share. The rise in chronic conditions like kidney disease, diabetes, and heart failure necessitates consistent urine output monitoring.

In 2023, the North American market recorded USD 202.4 million in revenue and is projected to grow at a CAGR of 6.7% from 2024 to 2032. The increasing prevalence of chronic diseases such as diabetes, kidney disease, and cardiovascular disorders drives this demand.

Key players include Advin Health Care, Angiplast Private Limited, B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, Inc., Convatec Inc., Fannin, Forlong Medical Co., Ltd., Hitec Medical Co., Ltd., and Laborie.

Urometer Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 153
  • Countries covered: 23
  • Pages: 110
 Download Free Sample